Up-regulation of DcR3 in microbial toxins-stimulated HUVECs involves NF-κB signalling
Open Access
- 27 December 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Biochemistry
- Vol. 19 (1), 1-8
- https://doi.org/10.1186/s12858-018-0102-z
Abstract
Sepsis is a severe condition characterised by the body’s systemic inflammatory response to infection. The specific sepsis-related biomarkers should be used in clinical diagnosis, therapeutic response monitoring, rational use of antibiotics, and prognosis (risk stratification), etc. In this study, we investigated the expression level of Decoy Receptor 3 (DcR3) and the mechanism of high expression in sepsis patients. Septic cell model experiments were performed by treating human umbilical vein endothelial cells (HUVECs) and Jurkat cells with lipopolysaccharide (LPS), lipoteichoic acid (LTA) and zymosan, respectively. SP600125, SB203580 and ammonium pyrrolidinedithiocarbamate (PDTC) were used to inhibit JNK1/2, p38MAPK and NF-κB signalling pathways in septic cell model, respectively. These results showed that DcR3 levels were higher in sepsis group than control. DcR3 mRNA and protein levels in HUVECs were increased following treatment with LPS, LTA and zymosan, and also increased in Jurkat cells treated by LPS, but not by LTA or zymosan. When HUVECs were treated with the NF-κB inhibitor PDTC, DcR3 expression was decreased compared with controls. However, SP600125 and SB203580 had no effect on DcR3 mRNA or protein levels. The results indicated that DcR3 secretion proceeded through the NF-κB signalling pathway in HUVECs.Keywords
Funding Information
- Scientific Foundation of Shanghai Municipal Commission of Health and Family Planning (201540119, 20164Y0273)
- Science and Technology Research Project of Songjiang District of Shanghai (NO. 15SJGG25 and NO.15SJGG47)
- National Natural Science Foundation of China (81602131)
- National Natural Science Foundation of China (81702729)
This publication has 46 references indexed in Scilit:
- Role of biomarkers in the management of antibiotic therapy: an expert panel review: I – currently available biomarkers for clinical use in acute infectionsAnnals of Intensive Care, 2013
- ‘Decoy’ and ‘non-decoy’ functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cellsInternational Journal of Oncology, 2013
- Structural Mechanism for the Specific Assembly and Activation of the Extracellular Signal Regulated Kinase 5 (ERK5) ModuleOnline Journal of Public Health Informatics, 2013
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- TLRs and innate immunityBlood, 2009
- Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in mouse models of sepsisThe Journal of Experimental Medicine, 2008
- Elevated serum decoy receptor 3 with enhanced T cell activation in systemic lupus erythematosusClinical and Experimental Immunology, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its PromoterJournal of Virology, 2007
- Pathogen Recognition and Innate ImmunityCell, 2006